U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Drug Development Considerations for the Prevention of Healthcare-Associated Infections - 08/30/2022
  1. News & Events for Human Drugs

Workshop | Virtual

Event Title
Drug Development Considerations for the Prevention of Healthcare-Associated Infections
August 30, 2022


Date:
August 30, 2022
Time:
8:30 AM - 5:00 PM ET

Event Summary

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) co-sponsored this public virtual workshop on August 30, 2022.

The following topics were discussed:

  • The current state of development of pathogen-directed products used to prevent healthcare-associated infections
  • Evidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens
  • Antimicrobial resistance threats as potential targets for decolonization and pathogen reduction
  • Challenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections

Event Recording

Video transcript


Back to Top